Literature DB >> 1771972

Amino-terminal domain of the El Tor haemolysin of Vibrio cholerae O1 is expressed in classical strains and is cytotoxic.

R A Alm1, G Mayrhofer, I Kotlarski, P A Manning.   

Abstract

Previous studies have shown that the classical isolates of Vibrio cholerae possess an 11 bp deletion in the structural gene for the El Tor haemolysin leading to the production of a 27 kDa non-haemolytic truncated product HlyA* compared to the 82 kDa haemolysin, HlyA. These studies were designed to assess whether this truncated product had any biological activity. A KmR cartridge was introduced into the hlyA gene effectively eliminating the haemolysin. This was recombined into the chromosome of a variety of strains and isogenic pairs were examined in a number of systems. These studies suggest that the haemolytic (cytolytic) domain of HlyA resides at the C-terminus and that the N-terminus, which is conserved as HlyA* in classical strains, possesses enterotoxic (cytotoxic) activity. Experiments with the cholera-toxinless vaccine candidate JBK70 and its hlyA::KmR mutant suggest that HlyA* may be responsible for the residual diarrhoea observed in cholera-toxinless vaccine strains.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1771972     DOI: 10.1016/0264-410x(91)90247-4

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  23 in total

1.  Hemolysin and the multifunctional autoprocessing RTX toxin are virulence factors during intestinal infection of mice with Vibrio cholerae El Tor O1 strains.

Authors:  Verena Olivier; G Kenneth Haines; Yanping Tan; Karla J Fullner Satchell
Journal:  Infect Immun       Date:  2007-08-13       Impact factor: 3.441

2.  Mechanisms of inflammasome activation by Vibrio cholerae secreted toxins vary with strain biotype.

Authors:  Jessica Queen; Shivani Agarwal; Jazel S Dolores; Christian Stehlik; Karla J F Satchell
Journal:  Infect Immun       Date:  2015-04-06       Impact factor: 3.441

3.  Molecular analysis of Vibrio cholerae O1, O139, non-O1, and non-O139 strains: clonal relationships between clinical and environmental isolates.

Authors:  D V Singh; M H Matte; G R Matte; S Jiang; F Sabeena; B N Shukla; S C Sanyal; A Huq; R R Colwell
Journal:  Appl Environ Microbiol       Date:  2001-02       Impact factor: 4.792

4.  Characterization of the Vibrio cholerae El Tor lipase operon lipAB and a protease gene downstream of the hly region.

Authors:  M A Ogierman; A Fallarino; T Riess; S G Williams; S R Attridge; P A Manning
Journal:  J Bacteriol       Date:  1997-11       Impact factor: 3.490

5.  Cloning, characterization, and chromosomal mapping of a phospholipase (lecithinase) produced by Vibrio cholerae.

Authors:  A E Fiore; J M Michalski; R G Russell; C L Sears; J B Kaper
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

6.  Cytotoxic cell vacuolating activity from Vibrio cholerae hemolysin.

Authors:  A Coelho; J R Andrade; A C Vicente; V J Dirita
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

7.  Cell vacuolation, a manifestation of the El tor hemolysin of Vibrio cholerae.

Authors:  R Mitra; P Figueroa; A K Mukhopadhyay; T Shimada; Y Takeda; D E Berg; G B Nair
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

8.  CVD110, an attenuated Vibrio cholerae O1 El Tor live oral vaccine strain.

Authors:  J Michalski; J E Galen; A Fasano; J B Kaper
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

9.  Characterization of phenotypic, serological, and toxigenic traits of Vibrio cholerae O139 bengal.

Authors:  G B Nair; T Shimada; H Kurazono; J Okuda; A Pal; T Karasawa; T Mihara; Y Uesaka; H Shirai; S Garg
Journal:  J Clin Microbiol       Date:  1994-11       Impact factor: 5.948

10.  Vibrio cholerae cytolysin causes an inflammatory response in human intestinal epithelial cells that is modulated by the PrtV protease.

Authors:  Gangwei Ou; Pramod Kumar Rompikuntal; Aziz Bitar; Barbro Lindmark; Karolis Vaitkevicius; Sun Nyunt Wai; Marie-Louise Hammarström
Journal:  PLoS One       Date:  2009-11-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.